Stock Analiz

Inventiva S.A. IVA

Biotechnology: Pharmaceutical Preparations · IPO 2020 · data as of November 13, 2026

$3.68Market cap $870M
Open the interactive analysis →

Inventiva S.A. (IVA) is a healthcare company listed in the US with a market value of about $870M. In fiscal year 2025 it had revenue of $5M and net income of -$390M, a net margin of -7899.6%.

Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 4% a year, a 5-year average ROIC of -120%.

About Inventiva

Inventiva is listed in the US and classified in biotechnology: pharmaceutical preparations, IPO year 2020. Revenue went from $8M in 2018 to $5M in 2025, a decline of about 7.4% a year. It was profitable in 0 of the last 8 years in our data. Its share count fell by 21% over three years (buybacks).

Score: 0.6 / 5

Value0/5
Future growth1/5
Track record0/5
Financial health1/5
Shareholder returns1/5

Checks passed

  • 3-year revenue growth above 10% a year
  • More cash than debt, or low debt to equity
  • Share count down over 3 years (buybacks)

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S321.2
P/B13.4
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-13.3%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)-40.2%
Revenue growth (5 yrs, per year)3.8%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-647.8%
ROIC (5-yr avg.)-119.8%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 8 years

Fiscal year20252024202320222021202020192018
Revenue$5M$15M$26M$20M$10M$6M$13M$8M
Net income-$390M-$191M-$122M-$58M-$56M-$41M-$34M-$38M
Free cash flow-$116M-$89M——-$54M-$38M——
EPS (diluted)$-2.09$-0.81$-0.52$-0.24$-0.24$-0.17$-0.14$-0.16
Net margin-7899.6%-1251.0%-476.7%-288.5%-583.9%-638.8%-267.6%-447.4%
ROIC——-368.0%-50.2%-41.6%-19.4%-57.7%-42.0%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Inventiva pay a dividend?

Not currently.

Is Inventiva a good stock to buy?

We do not give buy or sell advice. Inventiva scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.